These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9365604)

  • 21. The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation.
    D'Silva M; Candinas D; Achilleos O; Lee SJ; Dalgic A; Miki C; Mayer AD; McMaster P
    Transpl Int; 1994; 7 Suppl 1():S378-80. PubMed ID: 11271257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats.
    Yoshida S; Toyama Y; Aoki T; Nakamura J; Odaira H; Inagaki Y
    Transplant Proc; 2000 Nov; 32(7):2492-3. PubMed ID: 11120262
    [No Abstract]   [Full Text] [Related]  

  • 23. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
    Matsumoto Y; Hof RP
    Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
    [No Abstract]   [Full Text] [Related]  

  • 25. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 26. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 29. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
    D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P
    Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of a new immunosuppressive agent, KF20444, in rat cardiac transplantation.
    Nomura M; Yamashita K; Takehara M; Omura T; Nakajima H; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1206-7. PubMed ID: 10083539
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats.
    Sun Y; Chen X; Zhao J; Zou X; Li G; Li X; Shen B; Sun S
    Transpl Immunol; 2012 Aug; 27(1):19-24. PubMed ID: 22538197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
    [No Abstract]   [Full Text] [Related]  

  • 33. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
    Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW
    Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract]   [Full Text] [Related]  

  • 36. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
    Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
    Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat.
    Yeh LS; Gregory CR; Griffey SM; Lecouter RA; Hou SM; Morris RE
    Transplantation; 1997 Sep; 64(6):919-22. PubMed ID: 9326421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of accommodation after long-term survival of hamster xenografts in rats.
    Ribas Y; Molleví DG; Mestre M; Vidal A; Berenguer C; González R; Figueras J; Jaurrieta E; Mánezñez R
    Transplant Proc; 1999 Sep; 31(6):2633-4. PubMed ID: 10500752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.